NEO Deborah K. Ross buys between 15,001 and 50,000 shares
Jan 01, 2025, 5:42 PM
-10.19%
What does NEO do
NeoGenomics, a clinical laboratory company based in Fort Myers, Florida, specializes in cancer genetics diagnostic testing and pharma services, employing 2,100 staff since its IPO in December 2012. Its services include clinical cancer testing and advanced diagnostics for healthcare providers and pharmaceutical companies.
Representative Deborah K. Ross bought between 15,001 and 50,000 shares of NEO on 30 December.
📡️ Health Care
Politician Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
